Moreover, lung cancer patients with concordantly high expression of ZNF322A, Shh, and CD31 (ZNF322Ahigh/Shhhigh/CD31high) showed the worse OS (P=0.012; Figure 5D) and PFS (P=0.029; Figure 5E). This evidence concerns the gene ZNF322 and lung carcinoma.